Pleural mesothelioma is the most common form of mesothelioma. Pleural (pleura is the thin lining or coverings of lungs) mesothelioma generally occurs to individuals exposed to high level of asbestos. Exposure to high level of asbestos for 10 or more years is generally required for pleural mesothelioma to develop. Pleural mesothelioma may occur, like other forms of mesothelioma, even decades (sometimes as late as 30 years after last exposure to asbestos) after last exposure to asbestos.
Pleural mesothelioma may start as simple pleural disease such as calcification of pleura or thickening of pleural lining and it is not uncommon to diagnose them as pleural calcification, pleural thickening or pleural plaques. As these pleural diseases are not fatal disease, they may be ignored and later on these pleural diseases may lead to development of pleural mesothelioma. Pleural diseases may not be fatal but they impair normal functioning of lungs and should be addressed appropriately. If a patient with pleural disease gives a history of asbestos exposure even only for a brief period the diagnosis of pleural mesothelioma should be considered.
Pleural disease such as pleural plaques can be starting point of pleural mesothelioma, an aggressive form of cancer that occurs only due to exposure to asbestos and no other causative factor has been proven. Although pleura are the origin of pleural mesothelioma, it can spread to chest wall and other areas such as abdomen very fast.
Mesothelioma generally cause death within a year of diagnosis, but early detection by recognizing asbestos exposure can lead to early diagnosis and better survival. Early diagnosis and appropriate treatment can lead to longer survival than untreated and late diagnosis patients of mesothelioma.
Minnesota is well known for their iron ore, especially in the Northeastern Iron Range region of the state. The iron industry had taken a drastic downturn in the last two years but is now back in full demand, one of the quickest turnarounds in such a market.
Janet L. Abrahm, M.D. is co-investigator with David Sugerbaker on a study exploring the impact of bi-weekly palliative care assessment with patients diagnosed with malignant pleural mesothelioma. This investigation is part of a larger study led by Dr. Alice Kornblith, a senior research assistant at the Dana-Farber Cancer Institute. The study’s aim is to enroll 400 mesothelioma patients, compile information and identify the specific factors that make the biggest improvement in the quality of life over a period of 9 months.